State Street Corp Relay Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 4,300,216 shares of RLAY stock, worth $17.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,300,216

Previous 4,248,406 1.22%

Holding current value

$17.9 Million

Previous $27.7 Million 9.91%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.23 - $9.51 $322,776 - $492,713	51,810 Added 1.22%	4,300,216 $30.4 Million
Q2 2024 Aug 14, 2024	SELL	$5.9 - $8.02 $10.5 Million - $14.2 Million	-1,772,582 Reduced 29.44%	4,248,406 $27.7 Million
Q1 2024 May 15, 2024	BUY	$7.5 - $12.07 $8.38 Million - $13.5 Million	1,117,410 Added 22.79%	6,020,988 $50 Million
Q4 2023 Feb 14, 2024	SELL	$6.01 - $11.48 $18,096 - $34,566	-3,011 Reduced 0.06%	4,903,578 $54 Million
Q3 2023 Nov 14, 2023	SELL	$8.24 - $12.97 $19 Million - $29.9 Million	-2,304,208 Reduced 31.95%	4,906,589 $41.3 Million
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $13.3 Million - $24.3 Million	1,330,516 Added 22.63%	7,210,797 $90.6 Million
Q1 2023 May 15, 2023	SELL	$15.0 - $22.76 $5.76 Million - $8.74 Million	-384,216 Reduced 6.13%	5,880,281 $96.8 Million
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $36.8 Million - $62.4 Million	2,596,427 Added 70.78%	6,264,497 $93.6 Million
Q3 2022 Nov 15, 2022	SELL	$18.07 - $31.37 $20.1 Million - $34.8 Million	-1,110,349 Reduced 23.24%	3,668,070 $82.1 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $20.3 Million - $53.2 Million	1,524,727 Added 46.86%	4,778,419 $80 Million
Q1 2022 May 16, 2022	BUY	$20.26 - $32.36 $1.36 Million - $2.17 Million	67,170 Added 2.11%	3,253,692 $97.4 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $13.1 Million - $18.7 Million	504,846 Added 18.83%	3,186,522 $97.9 Million
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $13.8 Million - $17.6 Million	463,516 Added 20.9%	2,681,676 $84.6 Million
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $5.57 Million - $7.74 Million	202,584 Added 10.05%	2,218,160 $81.2 Million
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $22.4 Million - $42.4 Million	688,871 Added 51.92%	2,015,576 $69.7 Million
Q4 2020 Feb 16, 2021	BUY	$35.51 - $54.03 $30.1 Million - $45.9 Million	848,817 Added 177.62%	1,326,705 $55.1 Million
Q3 2020 Nov 10, 2020	BUY	$32.81 - $45.1 $15.7 Million - $21.6 Million	477,888 New	477,888 $20.4 Million

Others Institutions Holding RLAY

# of Institutions

204

Shares Held

156M

Call Options Held

207K

Put Options Held

40K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $500M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Relay Therapeutics, Inc. Transaction History